ETF Managers Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$172K Buy
16,647
+4,209
+34% +$50.9K 0.01% 597
2022
Q4
$147K Sell
12,438
-2,276
-15% -$35.2K 0.01% 486
2022
Q3
$309K Sell
14,714
-1,160
-7% -$32.3K 0.01% 552
2022
Q2
$485K Buy
15,874
+555
+4% +$18.9K 0.01% 500
2022
Q1
$640K Sell
15,319
-941
-6% -$41.5K 0.01% 419
2021
Q4
$734K Sell
16,260
-3,286
-17% -$149K 0.01% 412
2021
Q3
$1.01M Buy
19,546
+3,741
+24% +$227K 0.02% 269
2021
Q2
$1.01M Sell
15,805
-521
-3% -$33.5K 0.02% 273
2021
Q1
$1.47M Sell
16,326
-9,452
-37% -$968K 0.03% 229
2020
Q4
$2.39M Buy
25,778
+6,203
+32% +$569K 0.05% 182
2020
Q3
$2.04M Buy
19,575
+9,270
+90% +$999K 0.06% 157
2020
Q2
$777K Buy
+10,305
New +$768K 0.03% 210

Other funds holding EBS